Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 401–500 of 1,000
Pianezzi, E., Altomare, C., Bolis, S., Balbi, C., Torre, T., Rinaldi, A., Camici, G. G., Barile, L., & Vassalli, G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118538 · Cited by 43
O’Hare, B. J., Kim, C. S. J., Hamrick, S. K., Ye, D., Tester, D. J., & Ackerman, M. J. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.002950 · Cited by 41
Riedel, M., Jou, C. J., Lai, S., Lux, R. L., Moreno, A. P., Spitzer, K. W., Christians, E., Tristani-Firouzi, M., & Benjamin, I. J. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.017 · Cited by 44
Sapp, V., Aguirre, A., Mainkar, G., Ding, J., Adler, E., Liao, R., Sharma, S., & Jain, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-92988-1 · Cited by 40
Molecular and cellular neurocardiology in heart disease
Habecker, B. A., Bers, D. M., Birren, S. J., Chang, R. B., Herring, N., Kay, M. W., Li, D., Mendelowitz, D., Mongillo, M., Montgomery, J. M., et al. (2024) · The Journal of Physiology · doi:10.1113/jp284739 · Cited by 43
Modeling Inherited Cardiac Disorders: A Cell Is Worth a Thousand Genes
Sallam, K., Kodo, K., & Wu, J. C. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0182 · Cited by 41
Hartung, S., Schwanke, K., Haase, A., David, R., Franz, W., Martin, U., & Zweigerdt, R. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0351 · Cited by 46
Sheng, C. C., Amiri‐Kordestani, L., Palmby, T. R., Force, T. L., Hong, C. C., Wu, J. C., Croce, K., Kim, G., & Moslehi, J. J. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.05.008 · Cited by 43
Lei, C. L., Wang, K., Clerx, M., Johnstone, R. H., Hortigon-Vinagre, M. P., Zamora, V., Allan, A., Smith, G. L., Gavaghan, D. J., Mirams, G. R., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00986 · Cited by 40
Evolution of mathematical models of cardiomyocyte electrophysiology
Amuzescu, B. P., Airini, R., Epureanu, F. B., Mann, S. A., Knott, T., & Radu, B. M. (2021) · Mathematical Biosciences · doi:10.1016/j.mbs.2021.108567 · Cited by 46
Kuroda, Y., Yuasa, S., Watanabe, Y., Ito, S., Egashira, T., Seki, T., Hattori, T., Ohno, S., Kodaira, M., Suzuki, T., et al. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2017.01.002 · Cited by 40
Mioulane, M., Foldes, G., Ali, N. N., Schneider, M. D., & Harding, S. E. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9396-1 · Cited by 40
Canfield, S. G., Šepac, A., Sedlić, F., Muravyeva, M., Bai, X., & Bosnjak, Z. J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182655e96 · Cited by 39
Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
Chang, C.-Y., Ting, H.-C., Su, H., & Jeng, J. (2018) · Cell Transplantation · doi:10.1177/0963689718754560 · Cited by 41
Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao, M., Shao, N., & Garg, V. (2020) · Stem Cells · doi:10.1002/stem.3178 · Cited by 40
MicroRNA-365 regulates human cardiac action potential duration
Esfandyari, D., Idrissou, B. M. G., Hennis, K., Avramopoulos, P., Dueck, A., El‐Battrawy, I., Grüter, L., Meier, M. A., Näger, A. C., Ramanujam, D. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27856-7 · Cited by 45
Self-citationDifferentiation and enrichment of cardiomyocytes from human pluripotent stem cells
Xu, C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.012 · Cited by 38
Yamada, S., Nelson, T. J., Kane, G. C., Martinez‐Fernandez, A., Crespo‐Diaz, R. J., Ikeda, Y., Pérez-Terzic, C. M., & Terzic, A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.252288 · Cited by 38
Modelling familial dysautonomia in human induced pluripotent stem cells
Lee, G., & Studer, L. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0026 · Cited by 41
Barbuti, A., & Robinson, R. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009597 · Cited by 41
Heylman, C. M., Datta, R., Sobrino, A., George, S. C., & Gratton, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144572 · Cited by 40
Wuriyanghai, Y., Makiyama, T., Sasaki, K., Kamakura, T., Yamamoto, Y., Hayano, M., Harita, T., Nishiuchi, S., Chen, J., Kohjitani, H., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.05.028 · Cited by 40
El‐Battrawy, I., Müller, J., Zhao, Z., Cyganek, L., Zhong, R., Zhang, F., Kleinsorge, M., Lan, H., Li, X., Xu, Q., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00261 · Cited by 38
Giannetti, F., Benzoni, P., Campostrini, G., Milanesi, R., Bucchi, A., Baruscotti, M., Dell’Era, P., Rossini, A., & Barbuti, A. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02571-w · Cited by 40
El‐Battrawy, I., Lang, S., Zhao, Z., Akın, İ., Yücel, G., Meister, S., Patocskai, B., Behnes, M., Rudic, B., Tülümen, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166143 · Cited by 44
Sewanan, L. R., & Campbell, S. G. (2019) · The Journal of Physiology · doi:10.1113/jp276753 · Cited by 39
Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
Tang, S., Xie, M., Cao, N., & Ding, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00789 · Cited by 40
Lopez-Izquierdo, A., Warren, M., Riedel, M., Cho, S., Lai, S., Lux, R. L., Spitzer, K. W., Benjamin, I. J., Tristani-Firouzi, M., & Jou, C. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00344.2014 · Cited by 37
Kraushaar, U., Meyer, T., Hess, D., Gepstein, L., L Mummery, C., R Braam, S., & Guenther, E. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.639358 · Cited by 36
Chow, M. Z. Y., Boheler, K. R., & Li, R. A. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt308 · Cited by 43
Human induced pluripotent stem cells: A disruptive innovation
Vos, J. D., Bouckenheimer, J., Sansac, C., Lemaître, J.-M., & Assou, S. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.04.001 · Cited by 37
Wu, J., Wang, X., Chung, Y. Y., Koh, C. H., Liu, Z., Guo, H., Yuan, Q., Wang, C., Su, S., & Wei, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168435 · Cited by 37
Induced Pluripotent Stem Cells: An Emerging Theranostics Platform
Nelson, T. J., & Terzic, A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.304 · Cited by 37
Induced Pluripotent Stem Cell-Based Drug Screening by Use of Artificial Intelligence
Kusumoto, D., Yuasa, S., & Fukuda, K. (2022) · Pharmaceuticals · doi:10.3390/ph15050562 · Cited by 40
Ruvinov, E., Sapir, Y., & Cohen, S. (2012) · Synthesis lectures on tissue engineering · doi:10.2200/s00437ed1v01y201207tis009 · Cited by 37
The history, hotspots, and trends of electrocardiogram.
Yang, X., Liu, G., Tong, Y., Yan, H., Xu, Z. F., Chen, Q., Liu, X., Zhang, H.-H., Wang, H., & Tan, S. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.04.018 · Cited by 36
Transcription factors and atrial fibrillation
Mahida, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt261 · Cited by 37
Takaki, T., Inagaki, A., Chonabayashi, K., Inoue, K., Miki, K., Ohno, S., Makiyama, T., Horie, M., & Yoshida, Y. (2019) · Stem Cells International · doi:10.1155/2019/7532657 · Cited by 36
Brink, L., Grandela, C., Mummery, C. L., & Davis, R. P. (2020) · Stem Cells · doi:10.1002/stem.3110 · Cited by 38
Structures Illuminate Cardiac Ion Channel Functions in Health and in Long QT Syndrome
Brewer, K. R., Kuenze, G., Vanoye, C. G., George, A. L., Meiler, J., & Sanders, C. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00550 · Cited by 39
Jung, P., Seibertz, F., Fakuade, F. E., Ignatyeva, N., Sampathkumar, S., Ritter, M., Li, H., Mason, F. E., Ebert, A., & Voigt, N. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00912-z · Cited by 39
Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
Yang, J., Chen, S., Duan, F., Wang, X., Zhang, X., Lian, B. X., Kou, M., Chiang, Z., Li, Z., & Lian, Q. (2022) · Cells · doi:10.3390/cells11213511 · Cited by 37
Modeling Cancer with Pluripotent Stem Cells
Gingold, J. A., Zhou, R., Lemischka, I. R., & Lee, D. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.007 · Cited by 40
Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue
Fine, B. M., & Vunjak‐Novakovic, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00662 · Cited by 37
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias
Gnecchi, M., Stefanello, M., & Mura, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.085 · Cited by 36
Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Biendarra‐Tiegs, S. M., Secreto, F. J., & Nelson, T. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_350 · Cited by 38
Lin, H. P., McBride, K. L., Garg, V., & Zhao, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630069 · Cited by 37
Pasquale, E. D., Latronico, M. V. G., Jotti, G. S., & Condorelli, G. (2012) · Gene Therapy · doi:10.1038/gt.2012.19 · Cited by 38
Zhao, Q., Wang, X., Wang, S., Song, Z., Wang, J., & Ma, J. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0473-x · Cited by 35
Ventricular Tachycardia Due to Triggered Activity
Lerman, B. B., Markowitz, S. M., Cheung, J. W., Thomas, G. R., & Ip, J. E. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.10.033 · Cited by 34
Aggarwal, A., Stolear, A., Alam, M. M., Vardhan, S., Dulgher, M., Jang, S.-J., & ZARICH, S. W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061781 · Cited by 37
Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies
Sung, R. J., Hsiao, Tien, Lo, C., Juang, J. J., & Wang, Y.-H. (2013) · The Application of Clinical Genetics · doi:10.2147/tacg.s29676 · Cited by 38
Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders
Josowitz, R., Carvajal‐Vergara, X., Lemischka, I. R., & Gelb, B. D. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834598ad · Cited by 34
Guidelines for Translational Research in Heart Failure
Lara‐Pezzi, E., Menasché, P., Trouvin, J., Badimón, L., Ioannidis, J. P. A., Wu, J. C., Hill, J. A., Koch, W. J., Felice, A. F. D., Waele, P. D., et al. (2015) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-015-9606-8 · Cited by 34
Medicina personalizada: diagnóstico genético de cardiopatías/canalopatías hereditarias
Ackerman, M. J., Marcou, C. A., & Tester, D. J. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.12.010 · Cited by 39
Human induced pluripotent stem cells for monogenic disease modelling and therapy
Spitalieri, P., Talarico, V. R., Murdocca, M., Novelli, G., & Sangiuolo, F. C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.118 · Cited by 38
The contribution of non-coding regulatory elements to cardiovascular disease
Villar, D., Frost, S., Deloukas, P., & Tinker, A. (2020) · Open Biology · doi:10.1098/rsob.200088 · Cited by 35
In vitro human tissue models — moving towards personalized regenerative medicine
Schenke‐Layland, K., & Nerem, R. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.001 · Cited by 34
Stem cell–based biological pacemakers from proof of principle to therapy: a review
Chauveau, S., Brink, P. R., & Cohen, I. S. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.02.014 · Cited by 35
Proteomic Analysis of Human Fetal Atria and Ventricle
Lu, Z. Q., Sinha, A., Sharma, P., Kislinger, T., & Gramolini, A. O. (2014) · Journal of Proteome Research · doi:10.1021/pr5007685 · Cited by 36
Light-Activated Dynamic Clamp Using iPSC-Derived Cardiomyocytes
Quach, B., Krogh‐Madsen, T., Entcheva, E. G., & Christini, D. J. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.10.018 · Cited by 34
Joshi, J., Albers, C., Smole, N., Guo, S., & Smith, S. A. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1475152 · Cited by 33
Mehta, A. K., Verma, V., Nandihalli, M., Ramachandra, C. J. A., Sequiera, G. L., Sudibyo, Y., Chung, Y., Sun, W. Y., & SHIM, W. S. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103485 · Cited by 36
Concise Review: Human Pluripotent Stem Cell-Based Models for Cardiac and Hepatic Toxicity Assessment
Sartipy, P., & Björquist, P. (2011) · Stem Cells · doi:10.1002/stem.631 · Cited by 35
Inherited heart disease – what can we expect from the second decade of human i PS cell research?
Bellin, M., & Mummery, C. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12285 · Cited by 33
Self-citationGeometry-Dependent Arrhythmias in Electrically Excitable Tissues
McNamara, H. M., Dodson, S., Huang, Y., Miller, E. W., Sandstede, B., & Cohen, A. E. (2018) · Cell Systems · doi:10.1016/j.cels.2018.08.013 · Cited by 38
Chen, P., Xiao, Y., Wang, Y., Zheng, Z., Chen, L., Yang, X., Li, J., Wu, W., & Zhang, S. (2020) · Theranostics · doi:10.7150/thno.45172 · Cited by 40
Human Induced Pluripotent Stem Cells: The Past, Present, and Future
Hussein, S. M. I., Nagy, K. V., & Nagy, A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.37 · Cited by 35
Zhan, Y., Sun, X., Li, B., Cai, H., Xu, C., Liang, Q., Lü, C., Qian, R., Chen, S., Yin, L., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.007 · Cited by 32
Yan, Z., Zhong, L., Zhu, W., Chung, S. K., & Hou, P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106765 · Cited by 33
Clayton, Z. E., Sadeghipour, S., & Patel, S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.038 · Cited by 36
Mehta, A. K., Ramachandra, C. J. A., Sequiera, G. L., Sudibyo, Y., Nandihalli, M., Yong, P. J. A., Koh, C. H., & SHIM, W. S. N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.011 · Cited by 32
Shah, D., Prajapati, C., Penttinen, K., Cherian, R. M., Koivumäki, J. T., Alexanova, A., Hyttinen, J., & Aalto-Setälä, K. (2020) · Cells · doi:10.3390/cells9051153 · Cited by 31
“The expression ratios of HERG Finnish founder mutation (FinA) (p.L552S mutation) and HERG-wild type (WT) alleles were determined by plasmid-derived standard curve method (Moretti et al. 2010).”
BackgroundMethodGarate, Z., Davis, B. R., Bustamante, O. Q., & Segovia, J. C. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.251 · Cited by 34
Mura, M., Mehta, A. K., Ramachandra, C. J. A., Zappatore, R., Pisano, F., Ciuffreda, M. C., Barbaccia, V., Crotti, L., Schwartz, P. J., SHIM, W. S. N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.038 · Cited by 31
Ovics, P., Regev, D., Baskin, P., Davidor, M., Shemer, Y., Neeman-Egozi, S., Ben‐Haim, Y., & Binah, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197320 · Cited by 36
Cell Sheet‐Based Cardiac Tissue Engineering
Matsuura, K., Masuda, S., & Shimizu, T. (2013) · The Anatomical Record · doi:10.1002/ar.22834 · Cited by 35
iPSC Technology: Platform for Drug Discovery
Ellis, J., & Bhatia, M. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.22 · Cited by 31
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
Acab, A., & Muotri, A. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0354-x · Cited by 33
Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine
Parrotta, E. I., Scalise, S., Scaramuzzino, L., & Cuda, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225760 · Cited by 33
Kernik, D. C., Yang, P., Kurokawa, J., Wu, J. C., & Clancy, C. E. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008109 · Cited by 33
Cell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes
Boheler, K. R., & Poon, E. N.-Y. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02549-8 · Cited by 36
Personalized Medicine: Genetic Diagnosis for Inherited Cardiomyopathies/Channelopathies
Ackerman, M. J., Marcou, C. A., & Tester, D. J. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.12.010 · Cited by 36
Novel Insights into Disease Modeling Using Induced Pluripotent Stem Cells
Egashira, T., Yuasa, S., & Fukuda, K. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00960 · Cited by 32
Human-Induced Pluripotent Stem Cells: In Quest of Clinical Applications
Madonna, R. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9504-0 · Cited by 33
Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue
Mannhardt, I., Warncke, C., Trieu, H. K., Müller, J. W., & Eschenhagen, T. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2755 · Cited by 31
Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment
Kadota, S., & Shiba, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1171-3 · Cited by 33
Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
Bizy, A., & Klos, M. (2020) · Animals · doi:10.3390/ani10091561 · Cited by 26
Induced Pluripotent Stem Cells in Cardiovascular Medicine
Egashira, T., Yuasa, S., & Fukuda, K. (2011) · Stem Cells International · doi:10.4061/2011/348960 · Cited by 33
Darling, L. E. O., Vernon, A. N., Giovanniello, J. R., Lu, Y., Moshal, K. S., Roder, K., Li, W., & Koren, G. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00385.2012 · Cited by 30
Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
Ge, F., Wang, Z., & Xi, J. (2019) · Cells · doi:10.3390/cells9010009 · Cited by 29
McGivern, J. V., & Ebert, A. D. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.012 · Cited by 30
Waas, M., Weerasekera, R., Kropp, E. M., Romero‐Tejeda, M., Poon, E. N.-Y., Boheler, K. R., Burridge, P. W., & Gundry, R. L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.016 · Cited by 33
Ramachandra, C. J. A., Chua, J., Cong, S., Ja, K. P. M. M., SHIM, W. S. N., Wu, J. C., & Hausenloy, D. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa125 · Cited by 32
Zhu, K., Bao, X., Wang, Y., Lu, T., & Zhang, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113970 · Cited by 31
Abilez, O. J. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6346197 · Cited by 30
Harmer, S. C., Mohal, J. S., Kemp, D., & Tinker, A. (2012) · Biochemical Journal · doi:10.1042/bj20111912 · Cited by 29
Zhou, J., Wang, X., Zhang, S., Gu, Y., Yu, L., Wu, J., Gao, T., & Chen, F. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0260 · Cited by 29
Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology
Wu, J., Hunt, S. D., Xue, H., Liu, Y., & Darabi, R. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.01.003 · Cited by 29
Disease modelling using human iPSCs
Chamberlain, S. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw209 · Cited by 32
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.